This documentary features the stories of three patients with breast cancer who have benefitted from MammaPrint®.
Artist Yulia Brodskaya utilizes an ancient technique called quilling to weave individual declarations from members of the breast cancer community into portraits of these three patients.
MammaPrint FFPE is a FDA-cleared in vitro diagnostic test, performed in a central laboratory, using the gene expression profile obtained from formalin-fixed paraffin embedded (FFPE) breast cancer tissue samples to assess a patient’s risk for distant metastasis within 5 years. The test is performed for breast cancer patients, with Stage I or Stage II disease, with tumor size ≤ 5.0 cm and lymph node negative. The MammaPrint FFPE result is indicated for use by physicians as a prognostic marker only, along with other clinico-pathological factors.
The services discussed in this video are offered to educate consumers on healthcare and medical issues and should not substitute for medical advice, diagnosis or treatment. Talk to your health care provider for any questions regarding personal health or medical conditions.